Finance

Lists
RBGLY:OTCMKTS
Reckitt Benckiser Group PLC - ADR
$13.29
-1.70%
(-0.23) 1D
$13.29
0.00% (0.00)
After hours
Closed: Sep 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RBGLY...
Open
$13.29
High
$13.34
Low
$13.24
Mkt. cap
41.74B
Avg. vol.
503.17K
Volume
583.25K
Dividend
4.34%
Quarterly dividend
$0.14
Ex-dividend date
Aug 6, 2026
P/E ratio
11.24
52-wk high
$17.50
52-wk low
$12.02
EPS
$1.18
Beta
0.36
Shares outstanding
3.17B
No. of employees
36K
Open
$13.29
High
$13.34
Low
$13.24
Mkt. cap
41.74B
Avg. vol.
503.17K
Volume
583.25K
Dividend
4.34%
Quarterly dividend
$0.14
Ex-dividend date
Aug 6, 2026
P/E ratio
11.24
52-wk high
$17.50
52-wk low
$12.02
EPS
$1.18
Beta
0.36
Shares outstanding
3.17B
No. of employees
36K
News stories
From web sources and news partners
Profile
Reckitt is a British multinational consumer goods company headquartered in Slough, United Kingdom. It manufactures health and hygiene products. Reckitt's brands include the antiseptic brand Dettol, the sore throat medicine Strepsils, the toilet cleaner Harpic, the hair removal brand Veet, the cold, flu, and cough relief brand Mucinex, the indigestion remedy Gaviscon, the pain relief medication Nurofen and other brands and products like: Durex, Lysol, Finish, and Vanish. The company was formed in 1999 by the merger of British company Reckitt & Colman plc and Dutch company Benckiser N.V. Following the merger, the company was known as Reckitt Benckiser until 2021. Wikipedia
About Reckitt Benckiser Group PLC - ADR
CEOKris Licht
Employees36.2K
FoundedJun 6, 2007
HeadquartersSlough, Berkshire, United Kingdom
SectorHousehold goods
Websitereckitt.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.61B
3.61B
3.21B
3.21B
Cost of goods sold
1.42B
1.42B
1.33B
1.33B
Cost of revenue
1.42B
1.42B
1.33B
1.33B
Research and development expenses
158.00M
158.00M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.07B
1.07B
1.26B
1.26B
Operating expense
1.22B
1.22B
1.29B
1.29B
Total operating expenses
2.65B
2.65B
2.62B
2.62B
Operating income
963.50M
963.50M
583.00M
583.00M
Other non operating income
-2.00M
-2.00M
-
-
EBT including unusual items
1.26B
1.26B
490.50M
490.50M
EBT excluding unusual items
865.00M
865.00M
490.50M
490.50M
Income tax expense
143.50M
143.50M
162.00M
162.00M
Effective tax rate
11.37%
11.37%
33.03%
33.03%
Other operating expenses
-1.00M
-1.00M
-
-
Net income
1.11B
1.11B
326.00M
326.00M
Net profit margin
30.79%
30.79%
10.17%
10.17%
Earnings per share
-
-
-
-
Interest and investment income
8.50M
8.50M
30.00M
30.00M
Interest expense
-107.50M
-107.50M
-111.00M
-111.00M
Net interest expenses
-99.00M
-99.00M
-81.00M
-81.00M
Depreciation and amortization charges
-6.00M
-6.00M
-
-
EBITDA
1.02B
1.02B
778.50M
778.50M
Gain or loss from assets sale
-622.00M
-622.00M
-14.50M
-14.50M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps